Marco renoldi
Chief Business Officer
Pharmaceutical technology
EUBIOS SRL ENGINEERING COMPANY
New Zealand
Biography
Mr. Marco G. Renoldi, M.D. has been Chief Business Officer at NORDIC NANOVECTOR ASA since November 3, 2014. Prior to joining Nordic Nanovector, Mr. Renoldi served as SVP & Chief Commercial Officer at Shionogi Ltd., from July 2012 to October 2014. From January 2009 to June 2012 he served as Executive Director & International Franchise Head, Oncology-Hematology at Amgen, where he had previously led the Italian affiliate as Managing Director. Prior to joining Amgen, Mr. Renoldi held national, regional and global R&D and business roles at Novartis, Searle-Monsanto and Pharmacia. In his 28-year industry experience Mr. Renoldi has developed product lines and businesses, including start-ups. Mr. Renoldi holds a medical degree from the University of Milan and an MBA from Fondazione IDI/Assolombarda.
Research Interest
Nanomedicine Design of Nanodrugs Personalized Nanomedicine Nanomaterials for drug delivery
